My Stocks Explore Events Please signup to use this feature
Please signup to use this feature
Please signup to use this feature
Please signup to use this feature
Live today
{{event.ticker}} @{{event.event_utc_datetime | date:'h:mm a'}}
{{market.market_short_name}} {{market.last_price | number : 2}}

Want to join the conversation?

$UNH {{ '2015-07-16T12:43:27+0000' | timeago}} • Webcast

$UNH 2Q15 PR: UnitedHealth Group’s 2Q15 revenues of $36.3Bil, grew 11% or $3.7Bil YoverY. 2Q15 earnings from operations were $2.9Bil & net earnings of $1.64 per share increased 15% year over year. Second quarter net earnings grew 15% to $1.59Bil vs. $1.41 same quarter last year. The after-tax margin of 4.4% was steady, expanding 10BP YoverY.

User Melwyn Jones {{ '2016-10-28T17:16:30+0000' | timeago}}

$CVX posts first profit in a year. Right time to get some shares? My question is, will it sustain this turnaround?

User Josh Allan {{ '2016-10-27T15:39:01+0000' | timeago}}

Jeff Bezos, my inspiration next to Steve Jobs is going to review the Everything Store $AMZN's financial results today after hours. As an investor/user, I like Amazon Prime and it's success over several parts of the world. What's your take on Amazon?

User RC xNair {{ '2016-10-27T13:31:32+0000' | timeago}}

Of all the Wall St firms out there, Goldman Sachs $GS is the most revered for the way they're run - hiring the best, highly competitive, a closely-knit peer group and making tons of profits for the shareholders. An interesting interview of its CEO Llyod Blankfein by Carlyle groups chief David Rubenstein

User Ramesh Raju {{ '2016-10-27T10:38:07+0000' | timeago}}

Deutsche Bank posts Q3 net profit of 278 million euros.

User Vishnu Beri {{ '2016-10-27T01:52:28+0000' | timeago}}

Great results from $TSLA, however the question remains if Tesla can continue to scale up to produce the cars in the quantity it promises. Model 3 numbers need to be in multiples of what they are producing right now. Wish them the best, will keep an eye as I am still not convinced that they can scale easily.

$PFG {{ '2016-10-28T19:39:57+0000' | timeago}} • Webcast

Investment management firm $PFG launched five new funds in 3Q16. So far in 2016, the company has launched nine new funds.

$VTR {{ '2016-10-28T19:22:44+0000' | timeago}} • Webcast

$VTR stated that on contract cancellations, the company has modified the contract to convert single asset rights into more favorable and full contract provisions. $VTR added that the shop same store growth forecast would be the same even adjusting for the benefit of the Sunrise agreement.

$TFX {{ '2016-10-28T19:19:56+0000' | timeago}} • Announcement

$TFX said that its BoD declared a quarterly cash dividend of $0.34 per share of common stock. The dividend is payable Dec. 15, 2016 to shareholders of record at the close of business on Nov. 15, 2016.

$ESS {{ '2016-10-28T19:11:11+0000' | timeago}} • Webcast

$ESS had strong markets. The company’s rent cap which is basically at 10% along with the market strength led to loss-to-lease growth over time. $ESS currently has 1.9% loss-to-lease compared to 7.2% over a year ago.

$REGN {{ '2016-10-28T19:09:43+0000' | timeago}} • Announcement

$REGN and Sanofi said the U.S. Food and Drug Administration (FDA) issued a Complete Response Letter (CRL) regarding the Biologics License Application (BLA) for sarilumab. Sarilumab is an investigational interleukin-6 receptor (IL-6R) antibody for the treatment of adult patients with moderately to severely active rheumatoid arthritis (RA).